It was shown that endogenous type I IFN is required to initiate such an antitumor CD8+ T cell response, since mice of which the CD8α+ DCs lack IFNAR are unable to induce lymphocyte-mediated tumor rejection (41). This evidence concerns the gene CD8A and neoplasm.